Kawasaki disease and increased cardiovascular risk: Is there a link to circulating glycocalyx biomarkers?

André Jakob1, Sarah Bohlig1, Miriam König1

  • 1Ludwig-Maximilians-University of Munich, Department of Pediatric Cardiology, Marchioninistr. 15, 81377 Munich, Germany.

Microvascular Research
|October 26, 2021
PubMed

Insights

Kawasaki disease (KD) may alter endothelial glycocalyx, impacting long-term cardiovascular health. While not directly linked to KD, glycocalyx components interact with blood pressure and lipids in patients with a history of KD.

Area of Science:

  • Cardiovascular Research
  • Pediatric Rheumatology
  • Endothelial Biology

Background:

  • Kawasaki disease (KD) is an acute vasculitis with potential long-term cardiovascular consequences.
  • Endothelial glycocalyx dysfunction during KD may contribute to future vascular anomalies and atherosclerosis.
  • Investigating the link between glycocalyx components and cardiovascular risk factors in KD patients is crucial.

Purpose of the Study:

  • To assess circulating glycocalyx components (syndecan-1 and hyaluronan) in patients with a history of KD.
  • To analyze the association of these components with acute-phase KD clinical features.
  • To determine the relationship between glycocalyx components and current cardiovascular risk factors in KD survivors.

Main Methods:

  • Prospective observational cohort study of 31 KD patients and 20 healthy controls.
  • Serum syndecan-1 and hyaluronan measured by ELISA.
  • Analysis of acute-phase markers (blood counts, CRP, CAA) and current cardiovascular risk factors (blood pressure, lipids).

Main Results:

  • Hyaluronan and syndecan-1 levels were not directly associated with KD.
  • Syndecan-1 showed a significant association with acute-phase blood count alterations in KD patients.
  • Interactions between hyaluronan/syndecan-1 and cardiovascular risk factors (lipids, blood pressure) were observed exclusively in KD patients.

Conclusions:

  • Acute-phase vasculitis in KD may lead to persistent endothelial glycocalyx alterations.
  • These alterations can be influenced by concurrent vascular risk factors like blood pressure and lipids.
  • Findings suggest a potential pathway for long-term cardiovascular risk in Kawasaki disease survivors.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
483
Glycocalyx and its Functions01:14

Glycocalyx and its Functions

The glycocalyx is a carbohydrate-rich, fuzzy-appearing layer on the outer surface of the cell membrane. It is highly hydrophilic, because of this it attracts large amounts of water to the cell's surface. This aids the cell's interaction with the watery environment and also helps it to obtain substances dissolved in the water. It is also important for cell identification, self/non-self determination, and embryonic development and is used in cell-to-cell attachments to form tissues.
6.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
81
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
261
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.1K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
94